Sign in
Enrolling by invitationNo phase

Vein valve function after clot removal for acute deep vein thrombosis in the leg

Looks at vein valve function after AngioJet clot removal in leg thrombosis.

Key facts

Who runs it
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Where
China7 sites in 1 countryChoose a country to see its sites
Trial code
Registry title
Preservation of Venous Valvular Function After PMT for Acute DVT
Status
Enrolling by invitation
People taking part
100 people, planned
Started
6 Jun 2022
Expected to end
30 Dec 2026
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • AngioJet device
  • anticoagulation alone
Record updated
5 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a sudden, symptom-causing blood clot in the deep veins of the leg or pelvis. It studies how well the vein valves work after clot removal with a catheter device.

Age
18 Years to 80 Years
Sex
All sexes can join.
Disease stage
Acute, symptomatic deep vein thrombosis (DVT) close to the body's center. It involves the femoral, popliteal, common femoral and/or iliac veins.
Earlier treatment
Patients were treated with catheter-based clot removal (PCDT) using the Zelante device (Boston Scientific). One group gets anticoagulation (blood thinners) alone.

Main reasons for not taking part

  • Symptoms for more than 14 days

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • Patients with acute symptomatic proximal DVT involving the femoral, and/or popliteal vein, common femoral vein, iliac veins (with or without other involved ipsilateral veins) were enrolled at seven vascular centers in China. Patients were treated with PCDT via Zelante device (Boston Scientific)

Who cannot take part

  • Participants were excluded if they had symptoms for more than 14 days

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To evaluate the venous valvular function after pharmacomechanical thrombectomy (PMT) for acute femoral-popliteal venous thrombosis.

The 2 groups in the trial

  • Pharmacomechanical Catheter-directed Thrombolysis for acute DVTTreatment being tested

    AngioJet, Boston Scientific

    Treatment: AngioJet device

  • anticoagulation alone for acute DVTPlacebo, for comparison

    Treatment: anticoagulation alone

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Endovascular Thrombectomy for Femoral Popliteal Vein Thrombosis on Venous Valve Function Maintenance: a Single-center, Single-arm Prospective Observational Study
Plain-language title
Vein valve function after clot removal for acute deep vein thrombosis in the legGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT05588284, who can take part
Record updated
5 May 2026